Comparative Anti-Reflux Procedures in Neurologically Impaired Children
CARPNIC
1 other identifier
interventional
3
1 country
1
Brief Summary
This trial is a randomized controlled trial of two standard anti-reflux procedures, Nissen fundoplication versus gastrojejunal feeding tubes (GJ tubes), in children and adolescents with functional and intellectual impairment who have gastrostomy feeding tubes and medically refractory or severe gastroesophageal reflux disease (GERD). This is a pilot study to establish feasibility before initiating a multi-centered study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 18, 2011
CompletedFirst Posted
Study publicly available on registry
March 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedOctober 21, 2013
October 1, 2013
2.7 years
February 18, 2011
October 17, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
GERD-related hospitalization and ED visits
Parental interviews and chart reviews will be used to record all health care encounters. Each encounter will be classified as either GERD-related or not. GERD-related hospitalizations and ED visits will be further classified as; diagnostic testing, procedural problems, likely aspiration pneumonia (AP or bacterial pneumonia), respiratory distress of other etiology, or death from any cause.
12 months
Secondary Outcomes (11)
Health Related Quality of Life
12 months
Total length of stay
12 months
Complications from treatment
12 months
Complications from failure of treatment
12 months
Mortality
12 months
- +6 more secondary outcomes
Study Arms (2)
Fundoplication
ACTIVE COMPARATORDuring fundoplication surgery, the upper curve of the stomach (the fundus) is wrapped around the esophagus and sewn into place so that the lower portion of the esophagus passes through a small tunnel of stomach muscle. This surgery strengthens the valve between the esophagus and stomach (lower esophageal sphincter), which stops acid from backing up into the esophagus as easily.
Gastrojejunal (GJ) feeding tube
ACTIVE COMPARATORGastrojejunal (GJ) tube placement is an image guided technique in which a special soft feeding catheter is placed through an existing hole in the stomach (gastrostomy) into the small bowel (jejunum).
Interventions
During fundoplication surgery, the upper curve of the stomach (the fundus) is wrapped around the esophagus and sewn into place so that the lower portion of the esophagus passes through a small tunnel of stomach muscle. This surgery strengthens the valve between the esophagus and stomach (lower esophageal sphincter), which stops acid from backing up into the esophagus as easily.
Gastrojejunal (GJ) tube placement is an image guided technique in which a special soft feeding catheter is placed through an existing hole in the stomach (gastrostomy) into the small bowel (jejunum).
Eligibility Criteria
You may qualify if:
- patient is between 6 months and 18 years of age; AND
- patient has functional impairment classified by either gross motor functional classification of 3, 4 or 5 OR impaired function in walking, crawling/standing, rolling/sitting, arm use, hand use, ability to hold head up; AND
- patient has a gastrostomy; AND
- patient has intolerance of feedings or other complications attributed to GERD as defined below; AND
- patient has a positive GERD diagnostic evaluation as define below:
- GERD diagnostic evaluation will include the following investigations;
- endoscopy and biopsy for visual assessment and histology of the esophageal mucosa
- pH study and/or multichannel intraluminal impedance (MII) probe to detect and quantify gastroesophageal reflux
- GER demonstrated by:
- Reflux Esophagitis: Endoscopic appearance of mucosal breaks in the distal esophagus with or without pathologist diagnosis based on one or more biopsy histologic features of: inflammatory cellular infiltrate, basal cell hyperplasia, elongation of the vascular papillae AND no infectious microorganisms and \< 15 eosinophils per high power field; OR
- pH OR pH/multichannel intraluminal impedance(MII) probe evidence of pathologic GER:
- pH probe: acid reflux index \> 7 % OR
- pH/MII reflux symptom-associated acid or non-acid volume associated reflux events;
- Upper GI will only be used to determine normal anatomy; AND
- patient has either medically refractory GERD or severe GERD as defined below:
- +12 more criteria
You may not qualify if:
- Upper GI findings that would mandate a fundoplication including: hiatal hernia, esophageal stricture, Barret's esophagus; OR
- Upper GI findings show uncorrected distal gastrointestinal obstruction including: gastric outlet obstruction, duodenal obstruction, malrotation; OR
- Upper GI demonstrates structural foregut abnormalities that preclude a fundoplication including: microgastria, short esophagus, high anesthetic risk; OR
- Diagnosis or history of congenital diaphragmatic hernia, esophageal atresia, chronic intestinal pseudoobstruction; OR
- Endoscopy and biopsy demonstrates esophagitis from causes other than GER including: eosinophilic esophagitis, candida esophagitis, viral esophagitis); OR
- Rapidly changing or indeterminate neurological including either a deteriorating neurological condition such as rapid loss of developmental milestones or improving, such as rapid recovery following severe neurological insult; OR
- Patient has unacceptable general anesthetic risk; OR
- A previous Nissen fundoplication; OR
- Feeds delivered by GJ/NJ at the time of enrollment occurring for greater than 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Primary Children's Medical Center
Salt Lake City, Utah, 84113, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raj Srivastava, MD, MPH
University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Raj Srivastava, MD, MPH
Study Record Dates
First Submitted
February 18, 2011
First Posted
March 3, 2011
Study Start
January 1, 2011
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
October 21, 2013
Record last verified: 2013-10